CA2375771A1 - Acides nucleiques et proteines correspondant au gene abc1 humain - Google Patents

Acides nucleiques et proteines correspondant au gene abc1 humain Download PDF

Info

Publication number
CA2375771A1
CA2375771A1 CA002375771A CA2375771A CA2375771A1 CA 2375771 A1 CA2375771 A1 CA 2375771A1 CA 002375771 A CA002375771 A CA 002375771A CA 2375771 A CA2375771 A CA 2375771A CA 2375771 A1 CA2375771 A1 CA 2375771A1
Authority
CA
Canada
Prior art keywords
nucleic acid
abc1
nucleotide
sequence
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002375771A
Other languages
English (en)
French (fr)
Inventor
Patrice Denefle
Marie-Francoise Rosier-Montus
Isabelle Arnould-Reguigne
Catherine Prades
Laurent Naudin
Cendrine Lemoine
Nicolas Duverger
Gerd Assmann
Stephan Rust
Harald Funke
H. Bryan Brewer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9907684A external-priority patent/FR2795091B1/fr
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of CA2375771A1 publication Critical patent/CA2375771A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
CA002375771A 1999-06-17 2000-06-08 Acides nucleiques et proteines correspondant au gene abc1 humain Abandoned CA2375771A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR99/07684 1999-06-17
FR9907684A FR2795091B1 (fr) 1999-06-17 1999-06-17 Acides nucleiques et proteines du gene abc1 humain et leur application en therapie et diagnostic
US14712899P 1999-08-04 1999-08-04
US60/147,128 1999-08-04
PCT/FR2000/001595 WO2000078970A1 (fr) 1999-06-17 2000-06-08 Acides nucleiques et proteines correspondant au gene abc1 humain

Publications (1)

Publication Number Publication Date
CA2375771A1 true CA2375771A1 (fr) 2000-12-28

Family

ID=26234994

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002375771A Abandoned CA2375771A1 (fr) 1999-06-17 2000-06-08 Acides nucleiques et proteines correspondant au gene abc1 humain

Country Status (11)

Country Link
EP (1) EP1190063A1 (ja)
JP (1) JP2003503026A (ja)
KR (1) KR20020012279A (ja)
AU (1) AU5540800A (ja)
BR (1) BR0011724A (ja)
CA (1) CA2375771A1 (ja)
HU (1) HUP0204524A2 (ja)
IL (1) IL147071A0 (ja)
MX (1) MXPA01013062A (ja)
NO (1) NO20016089L (ja)
WO (1) WO2000078970A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2367955C (en) 1999-03-15 2009-05-19 University Of British Columbia Abc1 polypeptide and methods and reagents for modulating cholesterol levels
AU2002210636A1 (en) * 2000-10-31 2002-05-15 Aventis Pharma S.A. Polymorphic sequences of the human ABCA1 gene, their uses, detection methods and kits
FR2815970A1 (fr) * 2000-10-31 2002-05-03 Aventis Pharma Sa Sequences polymorphes du gene humain abca1, leurs utilisations, les methodes et kits de detection
NZ556415A (en) * 2002-01-02 2009-02-28 Genentech Inc Compositions and methods for the diagnosis and treatment of glioma tumor
CN112442114A (zh) * 2019-08-29 2021-03-05 渥太华Hdl药物研发公司 一种多肽及其应用

Also Published As

Publication number Publication date
WO2000078970A1 (fr) 2000-12-28
NO20016089D0 (no) 2001-12-13
MXPA01013062A (es) 2002-06-04
IL147071A0 (en) 2002-08-14
EP1190063A1 (fr) 2002-03-27
BR0011724A (pt) 2002-03-26
NO20016089L (no) 2002-02-15
AU5540800A (en) 2001-01-09
JP2003503026A (ja) 2003-01-28
HUP0204524A2 (hu) 2003-04-28
KR20020012279A (ko) 2002-02-15

Similar Documents

Publication Publication Date Title
JP4726302B2 (ja) Ａｂｃ１ポリペプチドおよびコレステロール水準を調節する方法と試薬
JP5416053B2 (ja) トリアシルグリセロールリパーゼファミリーのｌｌｇポリペプチド、組成物、酵素的加水分解における使用のための方法、タンパク質及び遺伝子治療
EP0915973A1 (fr) Gene implique dans le cadasil, methode de diagnostic et application therapeutique
CA2375771A1 (fr) Acides nucleiques et proteines correspondant au gene abc1 humain
EP1096012A1 (en) Nucleics acids of the human ABC1 gene and their therapeutic and diagnostic application
US20030044895A1 (en) Nucleic acids of the human ABCA5, ABCA6, ABCA9, AND ABCA10 Genes, vectors containing such nucleic acids, and uses thereof
FR2809414A1 (fr) Acide nucleique regulateur du gene abc1, molecules modulant son activite et applications therapeutiques
US20030059793A1 (en) Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereof
EP1183350A2 (fr) Produits d'expression de genes impliques dans des affections du metabolisme du cholesterol
US20030087246A1 (en) Nucleic acids of the human ABCA12 gene, vectors containing such nucleic acids and uses thereof
WO2002090545A9 (fr) Acide nucleique codant le polypeptide cgl1 et application de cet acide nucleique et du polypeptide cgl1 au diagnostic et en therapeutique
EP1334186A2 (fr) Acide nucleique regulateur du gene abca7, molecules modulant son activite et applications therapeutiques
FR2794131A1 (fr) Produits d'expression de genes impliques dans des affections associees au metabolisme du cholesterol
JP2004537983A (ja) ヒトａｂｃｃ１２遺伝子の核酸、このような核酸を含むベクター、およびこれらの使用
FR2795091A1 (fr) Acides nucleiques et proteines du gene abc1 humain et leur application en therapie et diagnostic
FR2822165A1 (fr) Acide nucleique regulateur du gene abca7, molecules modulant son activite et applications therapeutiques
KR20020059645A (ko) 인간 에이비씨1 유전자의 핵산과 이의 치료적 및 진단적적용
CA2511436A1 (fr) Proteine associee aux centrosomes et ses applications
JPH119287A (ja) Ａｔｇ−１１１７（ａｉｆ−３）、同種異型移植炎症性因子−１／ｒｃ−９の新規相同物

Legal Events

Date Code Title Description
FZDE Discontinued